NEW YORK (TheStreet) -- Stocks moved to session highs Friday in a heavy-volume quadruple-witching session following a two-day rally that was triggered by the Federal Reserve's promise to be "patient" in its approach to raising interest rates.
The S&P 500 was up 0.7%, the Dow Jones Industrial Average added 83 points, and the Nasdaq rose 0.58%.
Trading volume on domestic stock exchanges had exceeded the average 766 million shares traded over the previous four days. The high volume was due to Friday being a quadruple-witching session, one of four days of the year in which futures and options contracts expire at once.
Oil prices rebounded on Friday with West Texas Intermediate crude up 4.3% to $56.45 a barrel. Prices have been more volatile than usual over the past 24 hours after Saudi Arabia's oil minister, Ali al-Naimi, said OPEC wouldn't be able to stabilize oil prices alone lest it lose market share.
"It's just a reaction to perceptions that economic activity is not as weak as expected," said James Abate, CIO of Centre Funds, in a call. "It's silly to look into things from an intraday or day-to-day basis without looking at a longer trend and the trend is clearly down."
Energy shares were among the best performers of the market with the Energy Select Sector SPDR ETF (XLE) - Get Energy Select Sector SPDR Fund Report up 1.8%. Major oilers and oil services companies pulled the sector higher with Chevron (CVX) - Get Chevron Corporation Report climbing 2.5%, Schlumberger (SLB) - Get Schlumberger NV Report gaining 2.8%, and Kinder Morgan (KMI) - Get Kinder Morgan Inc Class P Report jumping 2.7%.
Veterinary drug developer Aratana Therapeutics (PETX) - Get Aratana Therapeutics, Inc. Report announced that its canine osteoarthritis pain drug had performed better in drug trials than a placebo. Shares rocketed 20% higher.
American Apparel (APP) - Get AppLovin Corp. Class A Report was reportedly approached by Irving Place Capital to discuss a possible takeover, according to The Wall Street Journal. Shares were up 9%, adding to an increase of more than 80% this week following the official termination of former CEO Dov Charney.
ImmunoGen (IMGN) - Get ImmunoGen, Inc. Report plummeted more than 35% on news Roche's clinical trials for a breast cancer treatment had failed to significantly improve patients' conditions. The treatment had been developed based on ImmunoGen technology.
In earnings Friday, BlackBerryundefined was diving 1.6% after revenue dropped by a third in its fiscal third quarter. Adjusted earnings of a penny beat expectations for a loss of 5 cents a share.
CarMax (KMX) - Get CarMax, Inc. Report added 10% as third-quarter profit beat forecasts and revenue jumped 16%. Finish Line (FINL) tumbled 18% as 2015 profit guidance of $1.67 a share missed consensus by 11 cents.
Nike (NKE) - Get NIKE, Inc. Class B Report , though it beat quarterly earnings forecasts, caused concern when it reported the slowest growth rate of future orders in four quarters. Shares were 1.8% lower.
--Written by Keris Alison Lahiff in New York.